BPG is committed to discovery and dissemination of knowledge
Citation
Xie C, Alkhouri N, Elfeki MA. Role of incretins and glucagon receptor agonists in metabolic dysfunction-associated steatotic liver disease: Opportunities and challenges. World J Hepatol 2024; 16(5): 731-750 [PMID: 38818288 DOI: 10.4254/wjh.v16.i5.731]
Please LOGIN to submit a new comment.